This grant funds research and development of innovative, field-ready Orthoebolavirus diagnostics to enhance rapid detection and outbreak response, with a focus on resource-limited regions.
Funder: Infectious Diseases Society of America
Due Dates: July 31, 2026
Funding Amounts: Up to 12 awards; typical award size by use case: $150K–$800K; project durations 18–36 months.
Summary: Supports development of innovative, field-ready diagnostics and foundational research to improve rapid detection and outbreak response for Orthoebolavirus, especially in resource-limited regions.
Key Information: Access to BSL-4 facilities and outbreak specimens or strong endemic-country partnerships is required for most tracks.
This grant opportunity seeks proposals for the development of decentralized, field-ready diagnostics and foundational research aimed at closing critical gaps in Orthoebolavirus detection, as highlighted by the 2026 Bundibugyo Ebola outbreak. The initiative is designed to accelerate the creation and deployment of innovative diagnostic solutions that enable rapid, accurate detection in resource-limited and high-risk settings—particularly in regions such as the Democratic Republic of the Congo (DRC) and Uganda. Technical priorities span biomarker discovery, validation of alternative specimen types, robust diagnostic product development, early-warning surveillance, and strengthening of quality assurance and training infrastructure for frontline health workers. Proposals must demonstrate technical expertise, access to necessary facilities and specimens, and meaningful partnerships with institutions in endemic regions.